Related Experiment Videos
Fail-safe systems for the wearable artificial endocrine pancreas
The International Journal of Artificial Organs
|November 1, 1988
Summary
A fail-safe system is crucial for the wearable artificial endocrine pancreas. This system effectively monitors for various issues, ensuring safe and reliable long-term glycemic control for diabetics.
Area of Science:
- Biomedical Engineering
- Medical Devices
- Endocrinology
Background:
- Long-term clinical use of artificial endocrine pancreas requires robust safety mechanisms.
- Existing wearable artificial pancreas systems incorporate hardware and software alarms.
Purpose of the Study:
- To evaluate the efficacy of a fail-safe system for a wearable artificial endocrine pancreas.
- To assess the system's ability to ensure long-term glycemic control in diabetics.
Main Methods:
- Incorporation of hardware alarms for battery and pump issues.
- Implementation of software alarms for converter status, insulin levels, and glycemic parameters.
- Development of a software noise filter to mitigate sensor interferences.
- Detection of sensor abnormalities via analog-to-digital converter (AD converter) overflow/underflow.
Main Results:
- Hardware alarms effectively addressed battery and pump failures.
- Software alarms successfully detected conditions like hypoglycemia, hyperglycemia, and abnormal insulin delivery.
- The noise filter proved effective against artificial and exercise-induced sensor noise.
- Sudden sensor lead disconnections or short circuits were identified as AD converter overflow/underflow events.
- Gradual sensor output changes were accurately signaled by hyperglycemia or hypoglycemia alarms.
Conclusions:
- The integrated fail-safe system is essential for the wearable artificial endocrine pancreas.
- The system demonstrates utility in providing safe and effective long-term glycemic management for diabetic patients.
- Fail-safe mechanisms enhance the reliability and clinical applicability of artificial pancreas technology.